Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-07 Scimeca Dario General Counsel and Secretary Option exercise · Restricted Stock Units 10b5-1 −22,727 0
2023-06-07 Scimeca Dario General Counsel and Secretary Option exercise · Restricted Stock Units 10b5-1 −9,044 9,045
2023-05-04 Wadsworth Samuel C. Director Grant or award · Restricted Stock Units +126,075 126,075
2023-05-04 Frankel Stanley Director Grant or award · Restricted Stock Units +126,075 126,075
2023-05-04 Buehler Kevin Director Grant or award · Restricted Stock Units +126,075 126,075
2023-05-04 Pire Shari Lisa Director Grant or award · Restricted Stock Units +126,075 126,075
2023-05-04 Brown Melinda Director Grant or award · Restricted Stock Units +126,075 126,075
2023-05-04 Germano Geno J Director Grant or award · Restricted Stock Units +126,075 126,075
2023-04-27 List Alan Chief Medical Officer Sale 10b5-1 −7,771 $0.79 $6K 56,496
2023-04-26 List Alan Chief Medical Officer Option exercise 10b5-1 +26,027 64,267
2023-04-26 List Alan Chief Medical Officer Option exercise · Restricted Stock Units 10b5-1 −26,027 26,028
2023-04-11 Buehler Kevin Director Option exercise +5,701 5,701
2023-04-11 Buehler Kevin Director Option exercise · Restricted Stock Units −5,701 0
2023-03-22 Amoroso Michael President and CEO Sale 10b5-1 −46,999 $0.82 $39K 68,738
2023-03-21 Amoroso Michael President and CEO Option exercise 10b5-1 +102,535 115,737
2023-03-21 Amoroso Michael President and CEO Option exercise · Restricted Stock Units 10b5-1 −102,535 205,009
2023-03-17 Kelly John Alexander Chief Financial Officer Purchase +20,000 $0.86 $17K 245,614
2023-03-06 Scimeca Dario General Counsel and Secretary Sale −12,172 $1.07 $13K 50,063
2023-03-06 List Alan Chief Medical Officer Sale −9,473 $1.07 $10K 38,240
2023-03-03 Scimeca Dario General Counsel and Secretary Option exercise +27,558 62,235

Page 13 of 23 · 456 trades